198 related articles for article (PubMed ID: 32642410)
1. MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1.
Liang L; Fu J; Wang S; Cen H; Zhang L; Mandukhail SR; Du L; Wu Q; Zhang P; Yu X
Acta Pharm Sin B; 2020 Jun; 10(6):1036-1046. PubMed ID: 32642410
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1.
Zhang Y; Liu Y; Xu X
Transl Oncol; 2017 Jun; 10(3):410-418. PubMed ID: 28445844
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
Shi Y; Gong W; Lu L; Wang Y; Ren J
Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305
[TBL] [Abstract][Full Text] [Related]
4. MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMGB1-Mediated Autophagy.
Chen Y; Zhou X; Qiao J; Bao A
Cell Physiol Biochem; 2017; 41(4):1370-1382. PubMed ID: 28427045
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy.
Su Q; Liu Y; Lv XW; Ye ZL; Sun YH; Kong BH; Qin ZB
J Mol Cell Cardiol; 2019 Aug; 133():12-25. PubMed ID: 31145943
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-142-3p Inhibits Chondrocyte Apoptosis and Inflammation in Osteoarthritis by Targeting HMGB1.
Wang X; Guo Y; Wang C; Yu H; Yu X; Yu H
Inflammation; 2016 Oct; 39(5):1718-28. PubMed ID: 27447821
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-505-3p inhibits development of glioma by targeting HMGB1 and regulating AKT expression.
Cheng Z; Wang B; Zhang C
Oncol Lett; 2020 Aug; 20(2):1663-1670. PubMed ID: 32724408
[TBL] [Abstract][Full Text] [Related]
8. mir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1.
Luo J; Chen J; He L
Med Sci Monit; 2015 Dec; 21():4122-9. PubMed ID: 26720492
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis.
Wang Q; Liang D; Shen P; Yu Y; Yan Y; You W
Transl Oncol; 2021 Aug; 14(8):101045. PubMed ID: 34023560
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5.
Wang ZC; Huang FZ; Xu HB; Sun JC; Wang CF
Int J Biochem Cell Biol; 2019 Jun; 111():63-71. PubMed ID: 30710750
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-142-3p inhibits proliferation and induces apoptosis by targeting the high-mobility group box 1 via the Wnt/β-catenin signaling pathway in glioma.
Li C; Feng S; Chen L
Int J Clin Exp Pathol; 2018; 11(9):4493-4502. PubMed ID: 31949846
[TBL] [Abstract][Full Text] [Related]
12. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
Guo X; Liu Y; Zheng X; Han Y; Cheng J
Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
[TBL] [Abstract][Full Text] [Related]
13. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-142-3p inhibits hypoxia/reoxygenation‑induced apoptosis and fibrosis of cardiomyocytes by targeting high mobility group box 1.
Wang Y; Ouyang M; Wang Q; Jian Z
Int J Mol Med; 2016 Nov; 38(5):1377-1386. PubMed ID: 28025989
[TBL] [Abstract][Full Text] [Related]
15. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
Xiao P; Liu WL
Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein.
Wang H; Deng Z; Chen X; Cai J; Ma T; Zhong Q; Li R; Li L; Li T
Med Sci Monit; 2019 Mar; 25():2169-2178. PubMed ID: 30904920
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
[TBL] [Abstract][Full Text] [Related]
18. Mir-153-3p Modulates the Breast Cancer Cells' Chemosensitivity to Doxorubicin by Targeting KIF20A.
Rahman KU; Yang S; Azam N; Yuan Z; Yu J; Zhao C; Feng B
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980610
[TBL] [Abstract][Full Text] [Related]
19. miR-27b-3p is Involved in Doxorubicin Resistance of Human Anaplastic Thyroid Cancer Cells via Targeting Peroxisome Proliferator-Activated Receptor Gamma.
Xu Y; Han YF; Ye B; Zhang YL; Dong JD; Zhu SJ; Chen J
Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):670-677. PubMed ID: 29924913
[TBL] [Abstract][Full Text] [Related]
20. Overexpression miR-24-3p repressed Bim expression to confer tamoxifen resistance in breast cancer.
Han X; Li Q; Liu C; Wang C; Li Y
J Cell Biochem; 2019 Aug; 120(8):12966-12976. PubMed ID: 31001849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
